Anchiano Therapeutics Ltd., of Cambridge, Mass., appointed Stan Polovets chair of its board.
Applied Therapeutics Inc., of New York, appointed Charles Silberstein chief financial officer and head of business development.
Elevar Therapeutics Inc., of Salt Lake City, appointed Mark Gelder vice president of medical affairs.
Hyloris Pharmaceuticals SA, of Liege, Belgium, appointed Patrick Jeanmart chief financial officer.
Medivir AB, of Stockholm, appointed Yilmaz Mahshid CEO.
Orion Corp., of Espoo, Finland, appointed Outi Vaarala senior vice president for research and development and to its executive management board, effective June 1, 2020.
Springworks Therapeutics Inc., of Stamford, Conn., appointed Julie Hambleton to its board.
Vor Biopharma Inc., of Cambridge, Mass., appointed Nathan Jorgensen chief financial officer.